Horizon Therapeutics USA’s $1.6 Billion Credit Facility

Cahill represented the lead arrangers in the transaction.Horizon Therapeutics USA, Inc. executed its $1.6 billion incremental term B credit facility. Proceeds from the credit facility were used…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here